Fundamental Analysis (FA)
Framework: DCF Benchmarked
Join Palmy To Bypass The Blur →
For DVAX
Valuation Weak
28%
Profitability n.A.
Fin. Growth Balanced
50%
Leverage & Liquidity Weak
17%
Per Share Metrics Weak
33%
Fin. Health n.A.
Fundamental Analysis (FA)
Benchmarked
1 Financial Health
Metric Q4 Q1 Δ in %
Current Ratio 10.05 15.20 13.81
Debt/Assets n.A. n.A. n.A.
Debt/Equity n.A. n.A. n.A.
Net Debt/EBITDA -56.39 -8.48 19.44
Naive Interpretation member
2 Per Share
Metric Q4 Q1 Δ in %
Book Value -1.20 4.75 4.81
Cash -3.14 5.56 5.74
Capex 56.80 < 0.005 -0.01
Free Cash Flow 43.80 -0.13 0.09
Revenue -9.22 0.39 0.43
Naive Interpretation member
3 Profitability
Metric Q4 Q1 Δ in %
Gross Margin -7.07 0.78 0.84
Operating Margin -113.74 -0.33 -0.15
ROA 3924.70 < 0.005 < 0.005
ROE 3905.32 -0.01 < 0.005
ROIC -599.88 -0.01 < 0.005
Naive Interpretation member
4 Valuation
The "Valuation Entry" for the Focus of DVAX is permitted for members.
5 Growth
The "Growth Entry" for the Focus of DVAX is permitted for members.
6 Leverage & Liquidity
The "Leverage & Liquidity Entry" for the Focus of DVAX is permitted for members.